|
DPH3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64335212105016E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00319760779166E-11 |
| Normal-vs-Stage2 |
1.597890E-04 |
| Normal-vs-Stage3 |
6.51922960059892E-13 |
| Normal-vs-Stage4 |
1.95399252334028E-13 |
| Stage1-vs-Stage2 |
1.562010E-01 |
| Stage1-vs-Stage3 |
2.234000E-02 |
| Stage1-vs-Stage4 |
3.74469999999683E-05 |
| Stage2-vs-Stage3 |
4.022700E-03 |
| Stage2-vs-Stage4 |
3.69470000000094E-05 |
| Stage3-vs-Stage4 |
8.044200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85327317328665E-14 |
| Normal-vs-AfricanAmerican |
2.603000E-04 |
| Normal-vs-Asian |
2.46109999046951E-09 |
| Caucasian-vs-AfricanAmerican |
5.918200E-01 |
| Caucasian-vs-Asian |
4.491800E-01 |
| AfricanAmerican-vs-Asian |
3.435800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.61932706027801E-14 |
| Normal-vs-Female |
5.2859938648453E-12 |
| Male-vs-Female |
7.077400E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.85840051417586E-10 |
| Normal-vs-Age(41-60Yrs) |
3.09752223870419E-14 |
| Normal-vs-Age(61-80Yrs) |
4.67090033318129E-10 |
| Normal-vs-Age(81-100Yrs) |
8.706200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.502400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.785600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.744800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.573200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.199810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.116800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.248430E-01 |
| Classical-VS-Follicular |
3.310800E-01 |
| Classical-VS-Other |
8.172300E-02 |
| Classical-VS-Normal |
4.1730999766898E-09 |
| Tall-VS-Follicular |
2.884100E-02 |
| Tall-VS-Other |
2.793000E-01 |
| Tall-VS-Normal |
1.18709997387612E-09 |
| Follicular-VS-Other |
8.614000E-02 |
| Follicular-VS-Normal |
1.417899999967E-06 |
| Other-VS-Normal |
1.768190E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.56460425013461E-11 |
| Normal-vs-N1 |
9.68702895676188E-12 |
| N0-vs-N1 |
8.924100E-03 |
|
|
